Company News
-
FDA-approved Investigator-initiated Pre-market Clinical Trial of LAmbre™ Plus LAA Closure System Obtained Medical Insurance Coverage in the USLifeTech Scientific Corporation (Stock Code: 1302.HK) is pleased to announce that on 30 August 2022, an FDA-approved investigator-initiated pre-market clinical trial of its proprietary LAmbre™ Plus Left Atrial Appendage (LAA) Closure System has obtained medical insurance coverage in the United States2022 / 09 / 05
-
LifeTech Scientific Corporation（1302.HK）Announces 2022 Interim ResultsRevenue increased by 20.4%, net profit attributable to owners of the Company increased by 34.4% after excluding certain non-recurring items2022 / 08 / 31
-
LifeTech Scientific Corporation（1302.HK） Announces 2021 Annual ResultsLifeTech Scientific Corporation (LifeTech, 1302.HK), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced 2021 annual results.2022 / 03 / 30
